semaglutide news today The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed. Added A new study is raising

09/17/2025|5 minute read Featured Insights News James Sherer Comments on AI Pilot Regulation in Insurance Industry in Law360 Article 07/27/2026|1 minute read News Global War on Terrorism Memorial Foundation Unveils Conceptual Design for National Mall Site 07/27/2026|2 minute read News BakerHostetler Represents Cardinal Health in Strive Medical Acquisition 07/27/2026|1 minute read Blockchain Monitor The Weekly Blockchain Blog July 27, 2026 07/27/2026|6 minute read See All Insights

GLP-1s improve insulin sensitivity and reduce visceral fat, both of which are affected by estrogen decline

The mixture was immediately extruded at room temperature with a manual mini extruder (Avanti) through a 100-nm filter (Nuclepore, Whatman)

ARMRA Colostrum supports metabolic health at the cellular level by promoting efficient cellular communication and energy signaling

Jeff is incredible